1 results match your criteria: "Reference Center for Rare Disease CRMR DevGen[Affiliation]"

Gonadotropin administration to mimic mini-puberty in hypogonadotropic males: pump or injections?

Endocr Connect

April 2023

Pediatric Endocrinology Department, CHU Bicetre, Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Disease CRMR DevGen, Le Kremlin Bicêtre, Paris, France.

Objective: Newborns with congenital hypogonadotropic hypogonadism (CHH) have an impaired postnatal activation of the gonadotropic axis. Substitutive therapy with recombinant gonadotropins can be proposed to mimic physiological male mini-puberty during the first months of life. The aim of this study was to compare the clinical and biological efficacy of two treatment modalities of gonadotropins administration during mini-puberty in CHH neonates.

View Article and Find Full Text PDF